Effect of Intracoronary Glycoprotein IIb/IIIa Inhibitor and Manual Aspiration Thrombectomy on Primary Percutaneous Coronary Intervention Outcome in High Thrombus Burden Patients

Intracoronary Pharmacotherapy (Verapamil-Epinephrine-Adenosine) for Prevention of No Reflow during Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocar

Clinical and Angiographic Predictors of No-Reflow Phenomenon during Primary Percutaneous Coronary Intervention

Comparison between The Efficacy of Intracoronary Nitroglycerin versus Nitroglycerin Plus Glycoprotein Inhibitors for Treatment of Patients with Thrombolysis in Myocardial Infarcti

Clinical and Laboratory Predictors of No-reflow during Primary Percutaneous Coronary Intervention

Assessment of the Clinical and Procedural Predictive Factors ofNo-Reflow Phenomenon Following Primary Percutaneous CoronaryIntervention

The SYNTAX Score and Angiographic "No-Reflow" in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Impact of Intracoronary Adenosine Administration During Primary PCI

Predictors of No-Reflow Phenomenon after Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients

EFFECT OF LOCAL DELIVERY OF STREPTOKINASE BEFORE PRIMARY PERCUTANEOUS CORONARY INTERVENTION ON MICROVASCULAR PERFUSION IN ACUTE MYOCARDIAL INFARCTION PATIENTS